| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |